Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis
Study Details
Study Description
Brief Summary
The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks: two similar brachial plexus nerve block techniques that differ in their needle trajectory and injection site.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
To date, there has not been a study that has compared clinically the retroclavicular brachial plexus block to the supraclavicular brachial plexus block or other brachial plexus blocks. The aim of this study is to evaluate differences between ultrasound guided supraclavicular versus retroclavicular brachial plexus blocks, with primary focus on the incidence of diminished ipsilateral hemidiaphramatic excursion (ipsilateral phrenic nerve blockade). We will also evaluate differences between the two techniques in the success of producing surgical anesthesia, procedural time to perform the block (including imaging time and needling time), block onset time, ease of quality ultrasound needle visualization, and incidence of paresthesias, vascular puncture and pneumothorax. Lastly, we will observe and compare the distribution of motor and sensory blockade of the two techniques
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Supraclavicular BPNB Patients in this group will be randomized to receive an Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period. |
Procedure: Supraclavicular vs Retroclavicular Nerve Block
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve
|
Active Comparator: Retroclavicular BNPB Patients in this group will be randomized to receive an Ultrasound Guided Retroclavicular Brachial Plexus Nerve Block and outcomes will be measured over the perioperative and 1day time period. |
Procedure: Supraclavicular vs Retroclavicular Nerve Block
An ultrasound-guided supraclavicular or retroclavicular nerve block with 30 ml of 0.5% ropivicaine will be performed on patients scheduled for lower arm surgery; 25 ml to be delivered to the brachial plexus and 5 ml to the intercostal nerve
|
Outcome Measures
Primary Outcome Measures
- Incidence of IIpsilateral Diaphragmatic Paresis [30 minutes post block, then postoperatively]
As evidence by ipsilater diagphragmatic excursion measured by Mmode ultrasound
Secondary Outcome Measures
- Anesthetic and analgesic efficacy [30 minutes post block, then postoperatively]
Block success will be defined as onset of acceptable sensory and motor blockade
- Procedural times (imaging time and needling time), onset time, ease of placement, and block duration [at the time of block]
Ultrasonographic block imaging times (time between ultrasound probe placement on the patient and satisfactory image of target anatomy acquisition. needling time (time between needle insertion into the skin and the end of local anesthetic injection through the block needle), onset and duration of sensory block, and proceduralist's rating of ease of block performance will be measured.
- Complication rates [1 day]
Rates of vascular puncture, pneumothorax and paresthesias will be recorded
- Nerve block distribution [30 minutes post block]
measured through sensation (cold and pin prick) over dermatomes of the brachial plexus
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients scheduled for lower arm surgery
-
patients aged 18 years or older
-
patients ASA class I-III
Exclusion Criteria:
-
Patients unable to cooperate or consent to the study
-
pre-existing neuropathy
-
significant pulmonary disease
-
contralateral phrenic nerve or diaphragmatic dysfunction
-
allergy to local anesthetics
-
infection at needle insertion site
-
history of coagulopathy
-
BMI > 40 kg/m2
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kamen Vlassakov | Boston | Massachusetts | United States | 02115 |
Sponsors and Collaborators
- Brigham and Women's Hospital
Investigators
- Principal Investigator: Kamen Vlassakov, MD, kvlassakov@partners.org
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2015P001537